TapewireFind a company

person · Reporting owner

RUSSO PATRICIA F

Disclosed activity across 5 companies

Tapewire entity
10741
SEC CIK
0001023219

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
General Motors CoGM · Entity 2958DirectorDecember 31, 2025January 05, 2026
Hewlett Packard Enterprise CoHPE · Entity 2984DirectorSeptember 30, 2026October 02, 2026
Howmet Aerospace Inc.ARNC · Entity 2911DirectorJanuary 04, 2018January 05, 2018
KKR & Co. Inc.KKR · Entity 338DirectorDecember 11, 2025December 13, 2025
Merck & Co., Inc.MRK · Entity 2807DirectorMay 29, 2026June 02, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

General Motors Co

Report date December 31, 2025 · Filed January 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Share Units ("DSUs")SEC Table II · derivative / convertible securityDirect101,056 Reported balance After 2025-12-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-12-31 · Grant · Acquired 7,960 · Balance 101,056

F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

Deferred Share Units ("DSUs")SEC Table II · derivative / convertible securityDirect102,030 Reported balance After 2025-12-31 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2025-12-31 · Grant · Acquired 974 · Balance 102,030

F2: Represents dividends accrued on DSUs in 2025 that were credited as additional DSUs at the end of the year.

F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

Filing footnotes · ownership attribution and instrument terms

F1: Amounts credited as DSUs will be paid in cash after the non-employee director leaves the Board, valued at the average closing price of the Company's Common Stock during the quarter immediately preceding payment.

F2: Represents dividends accrued on DSUs in 2025 that were credited as additional DSUs at the end of the year.

Hewlett Packard Enterprise Co

Report date September 30, 2026 · Filed October 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Merrill Lynch368,831.0929 Reported balance After 2026-09-30 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2026-09-30 · Grant · Acquired 616 · Balance 368,831.0929

F1: These shares were issued to the reporting person pursuant to the Issuer's 2021 Stock Incentive Plan in lieu of Q2 cash retainer of $39,375 for Issuer's Board Year 2026.

F2: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of the Issuer's Board of Directors.

F3: The number of shares in column 5 includes 928.5987 vested restricted stock unit ("RSU") dividend equivalent rights at $47.39 per RSU credited to the reporting person's account on 07/15/26.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect8,776.3109 Reported balance After 2026-07-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-07-15 · Grant · Acquired 26.3109 · Balance 8,776.3109

F4: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer's common stock.

F5: As previously reported, on 05/01/26, the reporting person was granted 8,750 RSUs, all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 26.3109 dividend equivalent rights at $47.39 per RSU credited to the reporting person's account on 07/15/26.

Common StockSEC Table I · non-derivativeDirect15,318 Reported balance Holding disclosure · report date 2026-09-30 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 15,318

Filing footnotes · ownership attribution and instrument terms

F1: These shares were issued to the reporting person pursuant to the Issuer's 2021 Stock Incentive Plan in lieu of Q2 cash retainer of $39,375 for Issuer's Board Year 2026.

F2: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of the Issuer's Board of Directors.

F3: The number of shares in column 5 includes 928.5987 vested restricted stock unit ("RSU") dividend equivalent rights at $47.39 per RSU credited to the reporting person's account on 07/15/26.

F4: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer's common stock.

F5: As previously reported, on 05/01/26, the reporting person was granted 8,750 RSUs, all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 26.3109 dividend equivalent rights at $47.39 per RSU credited to the reporting person's account on 07/15/26.

Howmet Aerospace Inc.

Report date January 04, 2018 · Filed January 05, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect8,289 Reported balance After 2018-01-04 transaction · row 1
1 source row

Row 1 · 2018-01-04 · Grant · Acquired 170 · Balance 8,289

Common StockSEC Table I · non-derivativeIndirectBy Trust18,333 Reported balance Holding disclosure · report date 2018-01-04 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 18,333

F1: Held by a trust for the benefit of the reporting person. The reporting person is the trustee of the trust.

Filing footnotes · ownership attribution and instrument terms

F1: Held by a trust for the benefit of the reporting person. The reporting person is the trustee of the trust.

KKR & Co. Inc.

Report date December 11, 2025 · Filed December 13, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect88,464 Reported balance After 2025-12-11 transaction · row 1
1 source row

Row 1 · 2025-12-11 · Grant · Acquired 1,605 · Balance 88,464

F1: Represents restricted stock units of KKR & Co. Inc., which were granted under the Amended and Restated KKR & Co. Inc. 2019 Equity Incentive Plan on December 11, 2025 and will generally vest on December 1, 2026. Upon vesting, each restricted stock unit will be settled by delivery of one share of common stock of KKR & Co. Inc.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units of KKR & Co. Inc., which were granted under the Amended and Restated KKR & Co. Inc. 2019 Equity Incentive Plan on December 11, 2025 and will generally vest on December 1, 2026. Upon vesting, each restricted stock unit will be settled by delivery of one share of common stock of KKR & Co. Inc.

Merck & Co., Inc.

Report date May 29, 2026 · Filed June 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect62,390.7517 Reported balance After 2026-05-29 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-29 · Grant · Acquired 1,853.0997 · Balance 62,390.7517

F1: 1-for-1

F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3: Holdings include shares acquired in dividend reinvestment transactions.

Common StockSEC Table I · non-derivativeDirect13,148 Reported balance Holding disclosure · report date 2026-05-29 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 13,148

Filing footnotes · ownership attribution and instrument terms

F1: 1-for-1

F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3: Holdings include shares acquired in dividend reinvestment transactions.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 08, 2017 Filed Feb 9, 2017 17:52 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 5,000 $35.19 $175,950.00
Disclosure

SEC source: 0001225208-17-002699 · doc4.xml · nonDerivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2017 Filed Mar 2, 2017 23:11 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 GrantRestricted Stock Units · Derivative 28.187 Not disclosed Not disclosed
Disclosure

SEC source: 0001179706-17-000021 · edgar.xml · derivative · entry 3

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,252.4742

Underlying: Common Stock · 28.187 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17.

F4 · price: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17.

F4 · derivative.exercise_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17.

F4 · derivative.expiration_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17.

Read SEC document
December 31, 2016 Filed Jan 5, 2017 00:19 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 1,025 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-17-000020 · wf-form4_148357553590894.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,943

Underlying: Common Stock · 1,025 shares

Expires not disclosed

F2 · security: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · derivative.exercise_price: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · price: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · derivative.exercise_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

F2 · derivative.expiration_date: Pursuant to the Plan, dividends on the DSUs are credited in DSUs at the end of year.

Read SEC document
December 31, 2016 Filed Jan 5, 2017 00:19 UTC General Motors Co GM · Entity 2958 GrantDeferred Share Units · Derivative 4,469 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001467858-17-000020 · wf-form4_148357553590894.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,918

Underlying: Common Stock · 4,469 shares

Expires not disclosed

F1 · security: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · derivative.exercise_price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · price: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · derivative.exercise_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

F1 · derivative.expiration_date: Deferred share units of the Company's Common Stock ("DSUs") were awarded on December 31, 2016 pursuant to the General Motors Company Deferred Compensation Plan (the "Plan") for Non-Employee Directors. Each non-employee director is required to defer one-half of the $250,000 annual retainer fee for service on the Board of Directors into DSUs and may elect to defer more. The retainer fee is converted to DSUs based on the average closing price of the Common Stock for the previous calendar year, which was $31.33. Amounts credited as DSUs will be paid in cash after the director leaves the Board, valued at the average daily closing price of the Common Stock for the quarter immediately preceding payment.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 00:56 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 GrantCommon Stock 1,050 $23.80 $24,990.00
Disclosure

SEC source: 0001179706-16-000537 · edgar.xml · nonDerivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,318

F1 · price: These shares were issued to the reporting person pursuant to the Issuer's 2015 Stock Incentive Plan in lieu of Q3 cash retainer and chair fees of $25,000 for Issuer's Board Year 2016.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 22:33 UTC Howmet Aerospace Inc. ARNC · Entity 2911 GrantCommon Stock 3,112 $0.00 $0.00
Disclosure

SEC source: 0000004281-16-000221 · edgar.xml · nonDerivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,112

F1 · balance_after: On October 5, 2016, Arconic Inc. (formerly, Alcoa Inc.) effected a 1-for-3 reverse stock split of its Common Stock. The amount of securities reported on this Form 4 have been adjusted to reflect the reverse stock split.

Read SEC document
October 31, 2016 Filed Dec 2, 2016 00:56 UTC Hewlett Packard Enterprise Co HPE · Entity 2984 GrantRestricted Stock Units · Derivative 24.8907 Not disclosed Not disclosed
Disclosure

SEC source: 0001179706-16-000537 · edgar.xml · derivative · entry 3

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,224.2872

Underlying: Common Stock · 24.8907 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16.

F4 · price: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16.

F4 · derivative.exercise_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16.

F4 · derivative.expiration_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16.

Read SEC document
October 26, 2016 Filed Oct 28, 2016 22:08 UTC KKR & Co. Inc. KKR · Entity 338 GrantRestricted Equity Units · Derivative 10,088 $0.00 $0.00
Disclosure

SEC source: 0001140361-16-083918 · form4.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,088

Underlying: Common Units · 10,088 shares

Expires not disclosed

F1 · derivative.exercise_price: These restricted equity units of KKR & Co. L.P. were approved for grant under the KKR & Co. L.P. 2010 Equity Incentive Plan and will generally vest on October 1, 2017. Upon vesting, each restricted equity unit may be settled by delivery of one common unit of KKR & Co. L.P.

F1 · derivative.exercise_date: These restricted equity units of KKR & Co. L.P. were approved for grant under the KKR & Co. L.P. 2010 Equity Incentive Plan and will generally vest on October 1, 2017. Upon vesting, each restricted equity unit may be settled by delivery of one common unit of KKR & Co. L.P.

F1 · derivative.expiration_date: These restricted equity units of KKR & Co. L.P. were approved for grant under the KKR & Co. L.P. 2010 Equity Incentive Plan and will generally vest on October 1, 2017. Upon vesting, each restricted equity unit may be settled by delivery of one common unit of KKR & Co. L.P.

Read SEC document
October 03, 2016 Filed Oct 5, 2016 21:33 UTC Howmet Aerospace Inc. AA · Entity 2911 GrantPhantom Stock Units · Derivative 3,497 $10.06 $35,188.56
Disclosure

SEC source: 0000004281-16-000152 · edgar.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,086

Underlying: Common Stock · 3,497 shares

Expires not disclosed

F2 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of Alcoa common stock.

F3 · derivative.exercise_date: Phantom stock units were acquired under the Alcoa 2005 Deferred Fee Plan for Directors and are to be paid out in cash after Board service ends.

F3 · derivative.expiration_date: Phantom stock units were acquired under the Alcoa 2005 Deferred Fee Plan for Directors and are to be paid out in cash after Board service ends.

Read SEC document
October 01, 2016 Filed Oct 4, 2016 22:03 UTC KKR & Co. Inc. KKR · Entity 338 Exercise / conversionRestricted Equity Units · Derivative 6,219 $0.00 $0.00
Disclosure

SEC source: 0001104659-16-148679 · a4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Units · 6,219 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: 6,219 restricted equity units of KKR & Co. L.P. vested on October 1, 2016 and were settled for common units of KKR & Co. L.P. on a one-for-one basis.

F1 · derivative.exercise_date: 6,219 restricted equity units of KKR & Co. L.P. vested on October 1, 2016 and were settled for common units of KKR & Co. L.P. on a one-for-one basis.

F1 · derivative.expiration_date: 6,219 restricted equity units of KKR & Co. L.P. vested on October 1, 2016 and were settled for common units of KKR & Co. L.P. on a one-for-one basis.

Read SEC document
October 01, 2016 Filed Oct 4, 2016 22:03 UTC KKR & Co. Inc. KKR · Entity 338 Exercise / conversionCommon Units 6,219 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-16-148679 · a4.xml · nonDerivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,495

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: 6,219 restricted equity units of KKR & Co. L.P. vested on October 1, 2016 and were settled for common units of KKR & Co. L.P. on a one-for-one basis.

Read SEC document
May 27, 2016 Filed May 31, 2016 19:57 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 3,009.915 $56.48 $170,000.00
Disclosure

SEC source: 0001225208-16-034172 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,408.59

Underlying: Common Stock · 3,009.915 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 29, 2015 Filed Jun 1, 2015 18:50 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 2,463.4587 $60.89 $150,000.00
Disclosure

SEC source: 0001225208-15-013058 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,686.6487

Underlying: Common Stock · 2,463.4587 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 30, 2014 Filed Jun 3, 2014 17:01 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 2,592.4646 $57.86 $150,000.00
Disclosure

SEC source: 0001225208-14-014285 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,684.4106

Underlying: Common Stock · 2,592.4646 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 31, 2013 Filed Jun 3, 2013 19:07 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 3,211.9914 $46.70 $150,000.00
Disclosure

SEC source: 0001225208-13-013654 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,577.1364

Underlying: Common Stock · 3,211.9914 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 25, 2012 Filed May 29, 2012 19:22 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 3,994.6738 $37.55 $150,000.00
Disclosure

SEC source: 0001225208-12-013303 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,935.0288

Underlying: Common Stock · 3,994.6738 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 27, 2011 Filed May 31, 2011 14:45 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 4,142.5021 $36.21 $150,000.00
Disclosure

SEC source: 0001225208-11-015342 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,641.0531

Underlying: Common Stock · 4,142.5021 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
August 04, 2010 Filed Aug 6, 2010 14:56 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $35.19 $0.00
Disclosure

SEC source: 0001225208-10-018706 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2020-08-03

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning August 4, 2011.

Read SEC document
May 28, 2010 Filed Jun 1, 2010 20:01 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 1,632.5319 $33.69 $55,000.00
Disclosure

SEC source: 0001225208-10-014289 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,395.0719

Underlying: Common Stock · 1,632.5319 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 17:33 UTC Merck & Co., Inc. MRK · Entity 2807 Disposition to issuerPhantom Stock · Derivative 71,514.21 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-09-021825 · doc4.xml · derivative · entry 2

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 71,514.21 shares

Expires not disclosed

F2 · derivative.exercise_price: Each unit was the economic equivalent of one share of Schering-Plough Corporation common stock.

F3 · price: In connection with the Transactions, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.

F3 · derivative.exercise_date: In connection with the Transactions, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.

F3 · derivative.expiration_date: In connection with the Transactions, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 17:33 UTC Merck & Co., Inc. MRK · Entity 2807 Disposition to issuerCommon Stock 9,652 $0.00 $0.00
Disclosure

SEC source: 0001225208-09-021825 · doc4.xml · nonDerivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,148

F1 · price: Pursuant to the Agreement and Plan of Merger ("Merger Agreement") by and among, inter alia, Merck & Co., Inc., formerly Schering-Plough Corporation, ("New Merck") and Merck Sharp & Dohme Corp., formerly Merck & Co., Inc., and upon the completion of the transactions contemplated therein (the "Transactions"), each common share of Schering-Plough Corporation common stock was converted into 0.5767 shares of New Merck common stock and $10.50 in cash. Any fractional share holdings were paid in cash pursuant to a formula in the Merger Agreement.

Read SEC document
November 03, 2009 Filed Dec 17, 2009 16:50 UTC Merck & Co., Inc. MRK · Entity 2807 GrantPhantom Stock · Derivative 747.2123 $30.67 Strike: $0.00 $22,917.00
Disclosure

SEC source: 0001225208-09-024624 · doc4.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 747.2123

Underlying: Common Stock · 747.2123 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Read SEC document
June 01, 2009 Filed Jun 2, 2009 16:48 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 1,567.62 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-09-000077 · rus739.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,266.84

Underlying: Common Shares · 1,567.62 shares

Expires not disclosed

F1 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan.

F2 · derivative.exercise_price: Not Applicable.

F5 · price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan.

F4 · derivative.expiration_date: Not Applicable.

F6 · balance_after: Includes shares acquired through May 26, 2009 pursuant to a dividend reinvestment feature of the Directors Compensation Plan.

Read SEC document
December 01, 2008 Filed Dec 1, 2008 22:53 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 8,149.91 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-08-000101 · rus691.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,455.85

Underlying: Common Shares · 8,149.91 shares

Expires not disclosed

F1 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan.

F2 · derivative.exercise_price: Not Applicable.

F5 · price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan.

F4 · derivative.expiration_date: Not Applicable.

F6 · balance_after: Includes shares acquired through November 25, 2008 pursuant to a dividend reinvestment feature of the Directors Compensation Plan.

Read SEC document
May 30, 2008 Filed May 30, 2008 21:27 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 5,418.35 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-08-000062 · rus677.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,081.8

Underlying: Common Shares · 5,418.35 shares

Expires not disclosed

F1 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan.

F2 · derivative.exercise_price: Not Applicable.

F5 · price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan.

F4 · derivative.expiration_date: Not Applicable.

F6 · balance_after: Includes shares acquired through May 27, 2008 pursuant to a dividend reinvestment feature of the Directors Compensation Plan.

Read SEC document
December 01, 2007 Filed Dec 4, 2007 21:53 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 3,434.5 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-07-000088 · rus638.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,514.14

Underlying: Common Shares · 3,434.5 shares

Expires not disclosed

F1 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan.

F2 · derivative.exercise_price: Not Applicable.

F5 · price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan.

F4 · derivative.expiration_date: Not Applicable.

F6 · balance_after: Includes shares acquired through November 27, 2007 pursuant to a dividend reinvestment feature of the Directors Compensation Plan.

Read SEC document
June 01, 2007 Filed Jun 4, 2007 20:48 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 3,283.44 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-07-000058 · rus627.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,991.75

Underlying: Common Shares · 3,283.44 shares

Expires not disclosed

F1 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan.

F2 · derivative.exercise_price: Not Applicable.

F5 · price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan.

F4 · derivative.expiration_date: Not Applicable.

F6 · balance_after: Includes shares acquired through May 29, 2007 pursuant to a dividend reinvestment feature of the Directors Compensation Plan.

Read SEC document
December 01, 2006 Filed Dec 4, 2006 20:55 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 4,884.14 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-06-000135 · rus590.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,636.98

Underlying: Common Shares · 4,884.14 shares

Expires not disclosed

F1 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan.

F2 · derivative.exercise_price: Not Applicable.

F5 · price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan.

F4 · derivative.expiration_date: Not Applicable.

F6 · balance_after: Includes shares acquired through November 30, 2006 pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan.

Read SEC document
June 01, 2006 Filed Jun 5, 2006 19:46 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 5,640.08 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-06-000091 · rus558.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,691.09

Underlying: Common Shares · 5,640.08 shares

Expires not disclosed

F1 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan.

F2 · derivative.exercise_price: Not Applicable.

F4 · price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan.

F2 · derivative.expiration_date: Not Applicable.

F5 · balance_after: Includes shares acquired through May 31, 2006 pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan.

Read SEC document
May 20, 2006 Filed May 23, 2006 19:57 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 3,000 $0.00 $0.00
Disclosure

SEC source: 0000310158-06-000065 · rus543.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,033.75

Underlying: Common Shares · 3,000 shares

Expires not disclosed

F1 · security: The stock units were credited pursuant to a deferral feature of the Directors Stock Award Plan.

F2 · derivative.exercise_price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock on dates selected in accordance with the Plan.

F4 · derivative.expiration_date: Not Applicable.

F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan, through February 28, 2006.

Read SEC document
April 01, 2006 Filed Apr 4, 2006 22:46 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Equivalent Units · Derivative 661.87 $18.99 $12,568.91
Disclosure

SEC source: 0000310158-06-000028 · rus527.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,913.58

Underlying: Common Shares · 661.87 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan.

F3 · derivative.exercise_date: Not Applicable.

F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer.

F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of February 28, 2006.

Read SEC document
January 01, 2006 Filed Jan 4, 2006 18:06 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Equivalent Units · Derivative 2,098.32 $20.85 $43,749.97
Disclosure

SEC source: 0000310158-06-000004 · rus514.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,167.56

Underlying: Common Shares · 2,098.32 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan and the Directors Stock Equivalency Program.

F3 · derivative.exercise_date: Not Applicable.

F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer.

F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 30, 2005.

Read SEC document
October 01, 2005 Filed Oct 4, 2005 19:23 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Equivalent Units · Derivative 445.37 $21.05 $9,375.04
Disclosure

SEC source: 0000310158-05-000077 · rus494.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,994.95

Underlying: Common Shares · 445.37 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan.

F3 · derivative.exercise_date: Not Applicable.

F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer.

F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program as of August 30, 2005.

Read SEC document
July 01, 2005 Filed Jul 5, 2005 22:47 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Equivalent Units · Derivative 491.86 $19.06 $9,374.85
Disclosure

SEC source: 0000310158-05-000060 · rus487.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,482.28

Underlying: Common Shares · 491.86 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan.

F3 · derivative.exercise_date: Not Applicable.

F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer.

F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program as of May 31, 2005.

Read SEC document
April 27, 2005 Filed Apr 29, 2005 19:22 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Units · Derivative 3,000 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000310158-05-000040 · rus465.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Shares · 3,000 shares

Expires not disclosed

F1 · security: The stock units were credited pursuant to a deferral feature of the Directors Stock Award Plan.

F2 · derivative.exercise_price: Not Applicable.

F4 · price: Not Applicable.

F3 · derivative.exercise_date: The stock units will be paid in shares of stock on dates selected in accordance with the Plan.

F2 · derivative.expiration_date: Not Applicable.

Read SEC document
April 01, 2005 Filed Apr 5, 2005 18:40 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Equivalent Units · Derivative 524.04 $17.89 Strike: $0.00 $9,375.08
Disclosure

SEC source: 0000310158-05-000005 · rus457.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,919.43

Underlying: Common Shares · 524.04 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan.

F3 · derivative.exercise_date: Not Applicable.

F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer.

F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of February 28, 2005.

Read SEC document
January 01, 2005 Filed Jan 4, 2005 19:47 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Equivalent Units · Derivative 2,095.31 $20.88 Strike: $0.00 $43,750.07
Disclosure

SEC source: 0001223203-05-000019 · rus450.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,323.86

Underlying: Common Shares · 2,095.31 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan and the Directors Stock Equivalency Program.

F3 · derivative.exercise_date: Not Applicable.

F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer.

F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of November 30, 2004.

Read SEC document
April 28, 2004 Filed Apr 29, 2004 21:29 UTC Merck & Co., Inc. SGP · Entity 2807 GrantCommon Shares 3,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000310158-04-000073 · rus392.xml · nonDerivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,800

F1 · price: Not Applicable.

Read SEC document
January 01, 2004 Filed Jan 5, 2004 23:35 UTC Merck & Co., Inc. SGP · Entity 2807 GrantStock Equivalent Units · Derivative 1,437.61 $17.39 Strike: $0.00 $25,000.04
Disclosure

SEC source: 0000310158-04-000010 · rus321.xml · derivative · entry 1

RUSSO PATRICIA F · CIK 0001023219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,950.42

Underlying: Common Shares · 1,437.61 shares

Expires not disclosed

F1 · derivative.exercise_price: 1 for 1

F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program.

F3 · derivative.exercise_date: Not Applicable.

F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer.

F5 · balance_after: Includes 496.61 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, through November 26, 2003.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.